REG - F&C Investment Trust - Portfolio Update

F&C Investment TrustAnnouncement

17/03/2022 11:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220317:nRSQ1419Fa&default-theme=true

RNS Number : 1419F  F&C Investment Trust PLC  17 March 2022

F&C INVESTMENT TRUST PLC

LEI: 213800W6B18ZHTNG7371

All data as at 28 February 2022

 

This data will shortly be available on the Company's website www.fandcit.com
(http://www.fandcit.com)

                                                                                                %

 Twenty Largest Listed Equity Holdings
 Microsoft                                                                                      2.3
 Alphabet                                                                                       2.0
 Amazon                                                                                         1.8
 Apple                                                                                          1.7
 UnitedHealth                                                                                   1.3
 Taiwan Semiconductor Manufacturing Company                                                     0.9
 Anthem                                                                                         0.8
 Hess                                                                                           0.8
 Meta                                                                                           0.7
 Comcast                                                                                        0.7
 International Flavors & Fragrances                                                             0.7
 Broadcom                                                                                       0.7
 Wells Fargo                                                                                    0.7
 Merck & Co                                                                                     0.6
 US Bancorp                                                                                     0.6
 CVS Health                                                                                     0.6
 Mastercard                                                                                     0.6
 JB Hunt                                                                                        0.6
 Dollar General                                                                                 0.6
 AstraZeneca                                                                                    0.6
 Total                                                                                          19.3

 Asset Allocation                                                                               %
 UK Equity                                                                                      8.8
 Europe ex UK Equity                                                                            14.9
 North America Equity                                                                           54.4
 Japan Equity                                                                                   6.6
 Developed Pacific Equity                                                                       2.3
 Emerging Markets Equity                                                                        8.8
 Liquidity                                                                                      4.1
 Total                                                                                          100.0

 Note: All percentages are based on Gross Assets. Figures are subject to
 rounding.

 Net Gearing                                                                                    9%

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFUBBGDXXDBDGDR